ARWR (Arrowhead Pharmaceuticals) Kacepetan wutah bathi saben saham ing taun lumaku

ARWR (Arrowhead Pharmaceuticals) - tandha merek perusahaan

The annual net income per share history for Arrowhead Pharmaceuticals (ARWR) demonstrates volatility, where the -5.00 indicator reflects the state of the metric. These fluctuations are driven by a lack of stable cash flows and a dependence on partner payments. High R&D expenditures keep margins low. The current development vector is based on strategic alliances and the acquisition of patents to create genetic medicines.

ARWR (Arrowhead Pharmaceuticals, Inc.) riwayat Wutah bathi ing taun lumaku saka 04.07.2022 nganti 15.11.2026

Rincian analitis lan laporan data perusahaan Arrowhead Pharmaceuticals, Inc. (ARWR)

- rega saham lan konsensus proyeksi valuasi:
Bagan rega Arrowhead Pharmaceuticals Inc|ARWR - Prakiraan konsensus analis
- indikator valuasi pasar bisnis:
Nilai pasar Arrowhead Pharmaceuticals, Inc.|ARWR - Nilai Total Perusahaan
- data ekuitas miturut neraca:
Nilai Akuntansi Saham Arrowhead Pharmaceuticals|ARWR - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku arrowheadpharma.com|ARWR - Aset Agregat Perusahaan
- rincian utang lan likuiditas:
Rasio Kabeh Utang marang Dana Pribadi Arrowhead Pharmaceuticals|ARWR - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Arrowhead Pharma|ARWR - Utang perusahaan|Utang-utang marang nilai buku Arrowhead Pharma|ARWR - Kewajiban jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Arrowhead Pharmaceuticals|Rasio jangkoan perantara arrowheadpharma.com
- indikator pendapatan resik lan kelipatan nilai:
ARWR - Bathi resik|Bathi resik sing dikarepake Arrowhead Pharmaceuticals|ARWR - Pangali P/E|Pangali Forward P/E Arrowhead Pharmaceuticals|ARWR - Pangali PEG|Nilai perusahaan marang bathi operasional sadurunge panyusutan Arrowhead Pharma|ARWR - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajroning taun lumaku Arrowhead Pharmaceuticals|ARWR - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan arrowheadpharma.com|ARWR - Wutah bathi ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Arrowhead Pharmaceuticals
- informasi babagan volume dodolan lan pendapatan:
ARWR - Pendapatan lan volume dodolan|Prakiraan volume dodolan Arrowhead Corp|ARWR - Rasio rega marang pendapatan|Rega forward marang dodolan Arrowhead Pharmaceuticals, Inc.|ARWR - Wutah dodolan YoY sajrone rolas wulan kepungkur
Analisis dhasar perusahaan:ARWR Arrowhead Pharmaceuticals
Produk sing diprodhuksi arrowheadpharma.com

For Arrowhead Pharmaceuticals (ARWR), which is developing a proprietary RNA interference R&D infrastructure, comparing EPS to the same period last year serves as an indicator of the efficiency of monetizing licensing agreements. This metric measures the annual trend of earnings per share, allowing for the rapid identification of fundamental business resilience or the risk of asset impairment relative to industry competitors through daily recalculations.

Pesaing wigati

MIRM (Mirum Pharma) - Wutah bathi saben saham ing taun lumaku|DVAX (Dynavax Corp) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku arbutusbio.com ABUS|Wutah bathi ing taun lumaku IVA|GYRE (Gyre Therapeutics) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku ASMB (Assembly Bio)|Owah-owahan bathi resik saben saham ing taun lumaku Galectin|Genfit Corp - Wutah bathi ing taun lumaku|DRRX - Wutah bathi ing taun lumaku|ALGS: Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku BioVie Inc. (BIVI)|Wutah bathi saben saham ing taun lumaku galmedpharma.com|NDRA: Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Hepion Pharmaceuticals (HEPA)